Literature DB >> 3876084

Risk factors for severe bacterial infections after valve replacement and aortocoronary bypass operations: analysis of 246 cases by logistic regression.

J Miholic, M Hudec, E Domanig, H Hiertz, W Klepetko, F Lackner, E Wolner.   

Abstract

Risk factors for severe bacterial infections, that is, deep sternal wound infection, pneumonia, septicemia, and prosthetic valve endocarditis, were evaluated in 246 consecutive patients undergoing valve replacement (N = 84) or aortocoronary bypass operation (N = 162). Multiple logistic regression analysis was applied to determine the ability of putative risk factors to predict infection. The risk factors considered were age, sex, diabetes mellitus, duration of cardiopulmonary bypass (CPB), duration of operation, amount of blood restored on the day of operation, repeat thoracotomy for bleeding, intraaortic balloon pumping, reoperation, emergency operation, and the professional status of the surgeon. Severe infections occurred in similar frequency after valve replacement (8/84; 9.5%) and aortocoronary bypass (11/162; 6.8%). For patients who had a bypass procedure, repeat thoracotomy was the only factor significantly associated with infection (p = 0.0004). However, the classification analysis revealed that this variable alone is too unspecific for a reliable prediction. Univariate analysis indicated that restoration of more than 2,500 ml of blood (p = 0.0001), reoperation (p = 0.0821), duration of operation (p = 0.0061), duration of CPB (p = 0.0318), and intraaortic balloon pumping (p = 0.0281) were associated with infection following valve replacement. A model with three variables emerged from the multiple logistic regression: after correction for blood restoration, reoperation, and duration of CPB, no other variable was of additional predictive value. For patients who underwent valve replacement, the model performed well in predicting complications. The classification analysis revealed a high correspondence between observed and predicted instances of infection: it correctly predicted 75% of the patients with infection and 96% of those without infection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876084     DOI: 10.1016/s0003-4975(10)60032-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.

Authors:  C Wenisch; A Bartunek; K Zedtwitz-Liebenstein; M Hiesmayr; B Parschalk; T Pernerstorfer; W Graninger
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

2.  Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery.

Authors:  G Pilz; S Kääb; E Kreuzer; K Werdan
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

Review 3.  Transfusion-associated bacterial sepsis.

Authors:  S J Wagner; L I Friedman; R Y Dodd
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  A clinical study of postoperative infections following open-heart surgery: occurrence and microbiological findings in 782 cases.

Authors:  H Orita; T Shimanuki; M Fukasawa; K Inui; S Goto; M Washio; H Horikawa
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

5.  [Perioperative cefamandole prevention in aortocoronary bypass operations: the course of serum levels in extracorporeal circulation].

Authors:  W Klepetko; A Georgopoulos; W Graninger; J Miholic; W Sandtner
Journal:  Langenbecks Arch Chir       Date:  1984

6.  Pacemaker implantation after aortic valve replacement: rapid-deployment Intuity® compared to conventional bioprostheses.

Authors:  Morgane Herry; Driss Laghlam; Olivier Touboul; Lee S Nguyen; Philippe Estagnasié; Alain Brusset; Pierre Squara
Journal:  Eur J Cardiothorac Surg       Date:  2020-08-01       Impact factor: 4.191

Review 7.  Perioperative haemotherapy: II. Risks and complications of blood transfusion.

Authors:  E T Crosby
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.